Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Steven T. Rosen"'
Autor:
Alex F Herrera, Lu Chen, Yago Nieto, Leona Holmberg, Patrick Johnston, Matthew Mei, Leslie Popplewell, Saro Armenian, Thai Cao, Leonardo Farol, Firoozeh Sahebi, Ricardo Spielberger, Robert Chen, Auayporn Nademanee, Sandrine Puverel, Mary Nwangwu, Peter Lee, Joo Song, Alan Skarbnik, Neena Kennedy, Lacolle Peters, Steven T Rosen, Larry W Kwak, Stephen J Forman, Tatyana Feldman
Publikováno v:
The Lancet Haematology. 10:e14-e23
Publikováno v:
JAAD Case Reports
JAAD Case Reports, Vol 14, Iss, Pp 37-42 (2021)
JAAD Case Reports, Vol 14, Iss, Pp 37-42 (2021)
Publikováno v:
Journal of Molecular Biology. 435:167968
Autor:
Xiwei Wu, James F. Sanchez, Ralf Buettner, Hongzhi Li, Steven T. Rosen, Laleh G. Melstrom, Corey Morales
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 14, Iss, Pp 149-158 (2019)
Molecular Therapy: Oncolytics, Vol 14, Iss, Pp 149-158 (2019)
The immunosuppressive agent leflunomide has been used in the treatment of over 300,000 patients with rheumatoid arthritis. Its active metabolite, teriflunomide (Ter), directly inhibits dihydroorotate dehydrogenase (DHODH), an enzyme involved in nucle
Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndrome
Autor:
Jasmine Zain, Farah Abdulla, Steven T. Rosen, X. Martinez, Cosimo Di Raimondo, Christiane Querfeld
Publikováno v:
Best Pract Res Clin Haematol
Mycosis fungoides (MF) and Sezary syndrome (SS) are the most common types of cutaneous lymphoma, accounting for approximately 60% of cutaneous T-cell lymphomas. Diagnosis requires correlation of clinical, histologic, and molecular features. A multitu
Autor:
Marcin Kortylewski, Xiwei Wu, Corey Morales, Lei Tian, Renee Estephan, Sung Hee Kil, Chingyu Su, Yate-Ching Yuan, Steven T. Rosen, Daniel Schmolze, Christiane Querfeld, Hanjun Qin, Jianhua Yu, Zhen Han, James F. Sanchez
Publikováno v:
J Invest Dermatol
Cutaneous T cell lymphoma (CTCL) is characterized by a background of chronic inflammation, where malignant CTCL cells escape immune surveillance. To study how microRNAs (miRs) regulate T-cell exhaustion, we performed miR sequencing analysis, qRT-PCR,
Autor:
Lihua E. Budde, Jasmine Zain, Leslie Popplewell, Matthew Mei, Robert T. Chen, Larry W. Kwak, Liana Nikolaenko, Alex F. Herrera, Tanya Siddiqi, Lu Chen, Steven T. Rosen
Publikováno v:
Transplantation and Cellular Therapy. 27:S47-S48
Autor:
Belén Rubio-González, Joan Guitart, Heather W. Wickless, Alba Posligua, Xiaolong Zhou, Kimberly A. Sable, Jaehyuk Choi, Maria Estela Martinez-Escala, Steven T. Rosen, Jason B. Kaplan, Audrey Rutherford, Christiane Querfeld, Barbara Pro
Publikováno v:
Journal of the American Academy of Dermatology. 78:1068-1076
Background Cutaneous lymphoma diagnosed after anti–tumor necrosis factor-α therapy (anti–TNF-α) has been reported in the literature, yet a clear link between both events remains elusive. Objective To review our experience with cutaneous lymphom
Autor:
Aliyah R. Sohani, Joycelynne Palmer, Alex F. Herrera, Yi-Bin Chen, Lihua E. Budde, Philippe Armand, Stephen J. Forman, Robert J. Soiffer, Christine Pak, Dennis D. Weisenburger, Amrita Krishnan, Jasmine Zain, Tanya Siddiqi, Wing C. Chan, Leslie Popplewell, Joseph H. Antin, Robert T. Chen, Liana Nikolaenko, John Koreth, Sarah Nikiforow, Dongyun Yang, Scott J. Rodig, German Pihan, Joyce Murata-Collins, Joo Y. Song, Matthew Mei, Larry W. Kwak, David M. Weinstock, Victoria Bedell, Corey Cutler, Auayporn Nademanee, Paola Dal Cin, Young L. Kim, Steven T. Rosen, Vincent T. Ho, Gabriel K. Griffin, Edwin P. Alyea, Raju Pillai
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:514-520
Double-hit lymphomas (DHLs) and double-expressor lymphomas (DELs) are associated with resistance to frontline and salvage immunochemotherapy, as well as autologous stem cell transplantation (SCT). We hypothesized that allogeneic SCT (alloSCT) could o
Autor:
Kenneth R. Carson, Jasmine Zain, X. Martinez, Michelle Afkhami, Christiane Querfeld, Steven T. Rosen, Charles L. Bennett, Vishwas Parekh, Farah Abdulla, Nicholas A. Trum
Publikováno v:
European Journal of Cancer. 156:S19
Mogamulizumab is a humanized antibody that targets CCR4, a transmembrane chemokine receptor predominantly expressed on effector T helper type 2 and malignant cutaneous T-cell lymphoma (CTCL) cells. This biologic was FDA approved for relapsed/refracto